Clinical Trial Update: Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temsirolimus in locally advanced or metastatic breast cancer has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2014-05-26